Prashanth Ray Profile Photo
Prashanth Ray
Prashanth Ray

Entrepreneur  ·  Executive (CEO/CPO)

Entrepreneur  ·  Executive (CEO/CPO)

Hyderabad, India

On Sabbatical

prashanth@nuevata.com

About me

Hello, I'm Prashanth Ray — a strategic and hands-on executive leader with 7+ years of experience building, scaling, and commercialising MedTech ventures across surgical devices, AI-enabled platforms, and regulated manufacturing. Proven ability to take healthcare innovations from lab → operating room → revenue, combining deep clinical workflow understanding with strong execution across product strategy, go-to-market, regulatory readiness, and capital planning.

Led ventures from zero to ₹7 crore ARR, built ISO 13485–certified manufacturing operations, secured seed funding, and established clinical adoption across tertiary hospitals and teaching institutions in India and globally. Known for hands-on leadership in ambiguous, resource-constrained environments for making high-leverage decisions that unlock product–market fit, operational scale, and investor confidence.

Experience

Hyderabad, India

Nuevata—Surgical Intelligence Platform

2025 – Present

Cofounder & Director

Building an AI-powered surgical intelligence platform combining a 4K head-mounted light & camera with SaaS analytics to quantify surgical actions, evaluate proficiency, and deliver post-operative insights.

  • Architecting a full-stack surgical intelligence platform integrating hardware (Nuevata Vision Device), cloud video processing, and AI-driven analytics for open surgical specialties

  • Designing a surgical video library, LIVE streaming engine, and tele-surgical assistance ecosystem to enable global mentorship, peer collaboration, and expert feedback at scale.

  • Leading fundraising building investor-ready pitch materials, financial models, and unit economics across a multi-stream revenue model (device sales, SaaS subscriptions, enterprise events, data services).

Nagpur, India

LUCID Implants

2019 – Present

Cofounder & Director

Hands-on founder-operator who built an end-to-end, surgeon-centric pipeline for patient-specific 3D-printed craniomaxillofacial and orthopaedic implants; drove 6× revenue growth, achieved ISO manufacturing scale, and sustained EBITDA-positive performance.

  • Grew annual revenue from ₹0 to ₹7 crore ARR and established a pipeline of ~100 monthly orders by building the commercial go-to-market engine for patient-specific craniomaxillofacial implants.

  • Scaled manufacturing from bench prototype to ISO 13485-certified cleanroom production facilities (metal & polymer additive manufacturing), increasing planned capacity from 288 to 4,032 units/year.

  • Secured MoUs with tertiary hospitals and teaching institutes (AIIMS Raipur, GDC Nagpur, HCG, KIMS), converting clinical engagements into recurring hospital contracts and government tender participation.

  • Built and managed a 50+ authorised distributor network; designed surgeon engagement programmes, workshops, and conference outreach that drove new-surgeon onboarding and repeat order frequency.

  • Led investor engagement and term-sheet negotiations for ~₹2 crore in angel funding to finance facility expansion, cleanroom build-out, and major capital expenditure.

Baltimore, USA

Johns Hopkins University

2018

Visiting Researcher

Invited to Johns Hopkins University for research on experimental bioinspired materials and healthcare 3D printing; outcomes directly informed the founding of LUCID Implants.

  • Conducted research on bioinspired materials and advanced 3D-printing technologies for healthcare applications under faculty mentorship at a top-ranked research institution. Translated experimental findings into a viable clinical pathway

Nagpur, India

BETiC, IIT Bombay

2017 – 2019

Researcher

Led transdisciplinary research on bioactive bone scaffolds using Hydroxyapatite (HA) and β-Tricalcium Phosphate (β-TCP) via additive manufacturing.

  • Engineered patient-matched porous scaffolds optimised for osteoconductivity and controlled resorption using additive manufacturing and biomaterial processing techniques.

  • Completed the full translational pipeline: systematic in-vitro characterisation, controlled in-vivo animal studies, and successful clinical case studies demonstrating bone regeneration.

  • Converted research outputs into a practical clinical pathway and manufacturing protocol: the direct technical foundation for founding LUCID Implants.

Education

Vancouver, Canada

Corporate Finance Institute® (CFI)

Financial Modeling & Valuation Analyst (FMVA)®

Financial modelling, valuation, DCF analysis, comparable company analysis, precedent transactions, accounting, strategy, and presentation design.

Nagpur, India

Visvesvaraya National Institute of Technology (VNIT)

Bachelor's Degree

National institute of importance; academic foundation in engineering complemented by entrepreneurial pursuits and translational research.